Top

Published in:

01-02-2004 | Poster presentation

Effect of levosimendan treatment on length of hospital and intensive care stay in the REVIVE I study

Authors: S Johansson, M Apajasalo, T Sarapohja, C Garratt

Published in: Critical Care | Special Issue 1/2004

Excerpt

Hospitalisation, especially length of stay in intensive care, is the main cost driver in heart failure (HF). Levosimendan, a novel calcium sensitiser, improves both short-term and long-term outcome of patients with acute HF. …

Title: Effect of levosimendan treatment on length of hospital and intensive care stay in the REVIVE I study
Authors: S Johansson
M Apajasalo
T Sarapohja
C Garratt
Publication date: 01-02-2004
Publisher: BioMed Central
Published in: Critical Care / Issue Special Issue 1/2004
Electronic ISSN: 1364-8535
DOI: https://doi.org/10.1186/cc2555

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Effect of levosimendan treatment on length of hospital and intensive care stay in the REVIVE I study

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Special Issue 1/2004

Antithrombin and free tri-iodothyronine in sepsis

Effect of albumin with furosemide in adult respiratory distress syndrome

Effects of recruitment maneuver and positive end-expiratory pressure on hypoxemia after pulmonary thromboendarterectomy for chronic pulmonary thromboembolism

The Duffy antigen receptor for chemokines (DARC) and acute renal failure (ARF) during lipopolysaccharide (LPS)-induced systemic inflammation

Predicting the response to therapy from a mathematical model

Effect of propofol on stroke volume and shunt in patients undergoing thoracic surgery with the exclusion of one-lung ventilation during planned operations